These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 35535267)
1. Decaprenyl Diphosphate Synthase Subunit 1 (PDSS1): A Potential Prognostic Biomarker and Immunotherapy-Target for Hepatocellular Carcinoma. Yang Y; Li J; Tang M; Nie B; Huang W Cancer Manag Res; 2022; 14():1627-1639. PubMed ID: 35535267 [TBL] [Abstract][Full Text] [Related]
2. A novel HCC prognosis predictor PDSS1 affects the cell cycle through the STAT3 signaling pathway in HCC. Rao Z; Li H; Yao W; Wang Q; Ma B; Xue D; Meng X Front Oncol; 2022; 12():927468. PubMed ID: 35965499 [TBL] [Abstract][Full Text] [Related]
3. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma. Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633 [TBL] [Abstract][Full Text] [Related]
4. Liu S; Zhao W; Li X; Zhang L; Gao Y; Peng Q; Du C; Jiang N Front Oncol; 2021; 11():713017. PubMed ID: 34595113 [TBL] [Abstract][Full Text] [Related]
5. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma. Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238 [TBL] [Abstract][Full Text] [Related]
6. DCK is a promising prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma. Song D; Wang Y; Zhu K; Tian L; Gao Q; Zhou J; Fan J; Wang X World J Surg Oncol; 2020 Jul; 18(1):176. PubMed ID: 32690026 [TBL] [Abstract][Full Text] [Related]
7. Xanthine dehydrogenase as a prognostic biomarker related to tumor immunology in hepatocellular carcinoma. Lin Z; Xie YZ; Zhao MC; Hou PP; Tang J; Chen GL Cancer Cell Int; 2021 Sep; 21(1):475. PubMed ID: 34496841 [TBL] [Abstract][Full Text] [Related]
8. The expression and prognostic value of GLYATL1 and its potential role in hepatocellular carcinoma. Guan R; Hong W; Huang J; Peng T; Zhao Z; Lin Y; Yu M; Jian Z J Gastrointest Oncol; 2020 Dec; 11(6):1305-1321. PubMed ID: 33457003 [TBL] [Abstract][Full Text] [Related]
9. Coiled-coil domain-containing protein 58 (CCDC58) is a novel prognostic biomarker correlated with mitochondrial functions in hepatocellular carcinoma. Chen L; Zhang J; Yang Y; Shu J; Zheng J; Zhan X; Guo M Am J Transl Res; 2023; 15(4):2568-2584. PubMed ID: 37193151 [TBL] [Abstract][Full Text] [Related]
10. Hydroxysteroid 17-Beta Dehydrogenase 6 Is a Prognostic Biomarker and Correlates with Immune Infiltrates in Hepatocellular Carcinoma. Wu M; Jiang L Dig Dis Sci; 2022 Jan; 67(1):146-158. PubMed ID: 33495920 [TBL] [Abstract][Full Text] [Related]
11. Phosphatidylinositol glycan anchor biosynthesis, class C is a prognostic biomarker and correlates with immune infiltrates in hepatocellular carcinoma. Zhao Q; Shen C; Wei J; Zhao C Front Genet; 2022; 13():899407. PubMed ID: 36061167 [No Abstract] [Full Text] [Related]
12. Comprehensive Analysis of HHLA2 as a Prognostic Biomarker and Its Association With Immune Infiltrates in Hepatocellular Carcinoma. Ding L; Yu Q; Yang S; Yang WJ; Liu T; Xian JR; Tian TT; Li T; Chen W; Wang BL; Pan BS; Zhou J; Fan J; Yang XR; Guo W Front Immunol; 2022; 13():831101. PubMed ID: 35371079 [TBL] [Abstract][Full Text] [Related]
13. Expression, immune infiltration and clinical significance of SPAG5 in hepatocellular carcinoma: A gene expression-based study. Chen W; Chen X; Li S; Ren B J Gene Med; 2020 Apr; 22(4):e3155. PubMed ID: 31860771 [TBL] [Abstract][Full Text] [Related]
14. CCL14 is a prognostic biomarker and correlates with immune infiltrates in hepatocellular carcinoma. Gu Y; Li X; Bi Y; Zheng Y; Wang J; Li X; Huang Z; Chen L; Huang Y; Huang Y Aging (Albany NY); 2020 Jan; 12(1):784-807. PubMed ID: 31927532 [TBL] [Abstract][Full Text] [Related]
15. RAB6B is a potential prognostic marker and correlated with the remolding of tumor immune microenvironment in hepatocellular carcinoma. Peng H; Zhu E; Wang J; Du X; Wang C; Yang M; Zhang Y Front Pharmacol; 2022; 13():989655. PubMed ID: 36120364 [No Abstract] [Full Text] [Related]
16. ASRGL1 Correlates With Immune Cell Infiltration in Hepatocellular Carcinoma and Can Serve as a Prognostic Biomarker. Xue C; Gao P; Cui X; Zhang X; Lei J; Li R; Zhu C; Qin X Front Oncol; 2021; 11():680070. PubMed ID: 34249720 [TBL] [Abstract][Full Text] [Related]
17. MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma. Ren X; Ju Y; Wang C; Wei R; Sun H; Zhang Q Cancer Invest; 2021 Oct; 39(9):756-768. PubMed ID: 34279157 [TBL] [Abstract][Full Text] [Related]
18. CCDC25 may be a potential diagnostic and prognostic marker of hepatocellular carcinoma: Results from microarray analysis. Deng H; Zhang J; Zheng Y; Li J; Xiao Q; Wei F; Han W; Xu X; Zhang Y Front Surg; 2022; 9():878648. PubMed ID: 36211267 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of CISD1 Predicts Worse Survival in Hepatocarcinoma Patients. Lu T; Li C; Xiang C; Gong Y; Peng W; Chen C Biomed Res Int; 2022; 2022():7823191. PubMed ID: 35313629 [TBL] [Abstract][Full Text] [Related]
20. Identification of Mitochondrial-Related Prognostic Biomarkers Associated With Primary Bile Acid Biosynthesis and Tumor Microenvironment of Hepatocellular Carcinoma. Zhang T; Nie Y; Gu J; Cai K; Chen X; Li H; Wang J Front Oncol; 2021; 11():587479. PubMed ID: 33868990 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]